Related references
Note: Only part of the references are listed.The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains
Frances Corrigan et al.
BRAIN RESEARCH (2011)
The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity
David R. Gibb et al.
MOLECULAR IMMUNOLOGY (2011)
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease
L. M. Bekris et al.
NEUROBIOLOGY OF AGING (2011)
Changes with Age in the Activities of β-Secretase and the Aβ-Degrading Enzymes Neprilysin, Insulin-Degrading Enzyme and Angiotensin-Converting Enzyme
J. Scott Miners et al.
BRAIN PATHOLOGY (2010)
被撤回的出版物: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10 (Retracted article. See vol. 158, pg. 959, 2014)
Gizem Donmez et al.
CELL (2010)
Platelet Alpha- and Beta-Secretase Activities are not Significantly Affected by Dementia or Mild Cognitive Impairment in Swedish Patients
P. Gorham et al.
CURRENT ALZHEIMER RESEARCH (2010)
ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2010)
β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation
Yan Cai et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-β
C. I. Jarvis et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Searching for new animal models of Alzheimer's disease
Roberta Epis et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Upregulation of the α-secretase ADAM10-risk or reason for hope?
Kristina Endres et al.
FEBS JOURNAL (2010)
Can Statins Prevent or Help Treat Alzheimer's Disease?
Bernadette McGuinness et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
BACE1 Activity in Cerebrospinal Fluid and Its Relation to Markers of AD Pathology
Sandra D. Mulder et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Statins and the Squalene Synthase Inhibitor Zaragozic Acid Stimulate the Non-Amyloidogenic Pathway of Amyloid-beta Protein Precursor Processing by Suppression of Cholesterol Synthesis
Elzbieta Kojro et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
BACE1 mRNA Expression in Alzheimer's Disease Postmortem Brain Tissue
David T. R. Coulson et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Expression of the Anti-amyloidogenic Secretase ADAM10 Is Suppressed by Its 5′-Untranslated Region
Sven Lammich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
An Arginine Stretch Limits ADAM10 Exit from the Endoplasmic Reticulum
Elena Marcello et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a β-Secretase-dependent Pathway
Nikolai D. Belyaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo
David R. Gibb et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and/or transcriptional role - relevance for Alzheimer pathology
Gennaro Schettini et al.
JOURNAL OF NEUROCHEMISTRY (2010)
BACE1 and BACE2 enzymatic activities in Alzheimer's disease
Rachel R. Ahmed et al.
JOURNAL OF NEUROCHEMISTRY (2010)
The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
Ellen Jorissen et al.
JOURNAL OF NEUROSCIENCE (2010)
Oral Administration of Synthetic Retinoid Am80 (Tamibarotene) Decreases Brain β-Amyloid Peptides in APP23 Mice
Kohichi Kawahara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein
Benjamin Harris et al.
BRAIN RESEARCH (2009)
Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin
Frank Tippmann et al.
FASEB JOURNAL (2009)
The effects of α-secretase ADAM10 on the proteolysis of neuregulin-1
Christian Freese et al.
FEBS JOURNAL (2009)
ADAM10, the Rate-limiting Protease of Regulated Intramembrane Proteolysis of Notch and Other Proteins, Is Processed by ADAMS-9, ADAMS-15, and the γ-Secretase
Thomas Tousseyn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
Shoumei Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway
Zoe V. Goodger et al.
JOURNAL OF CELL SCIENCE (2009)
CSF APPsα and Phosphorylated Tau Protein Levels in Mild Cognitive Impairment and Dementia of Alzheimer's Type
Andreas Fellgiebel et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2009)
A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10
Edward Parkin et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer
Jessica Pruessmeyer et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
The A Disintegrin And Metalloprotease (ADAM) family of sheddases: Physiological and cellular functions
Karina Reiss et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
Henrik Zetterberg et al.
ARCHIVES OF NEUROLOGY (2008)
Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme
Cristina Escrevente et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
Claudia Prinzen et al.
BMC GENOMICS (2008)
Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
Michael Ewers et al.
BRAIN (2008)
Decrease in age-adjusted cerebrospinal fluid β-secretase activity in Alzheimer's subjects
Guoxin Wu et al.
CLINICAL BIOCHEMISTRY (2008)
Part-time alpha-secretases: The functional biology of ADAM 9, 10 and 17
Miriam Deuss et al.
CURRENT ALZHEIMER RESEARCH (2008)
Alpha-secretase as a therapeutic target
Falk Fahrenholz
CURRENT ALZHEIMER RESEARCH (2007)
β-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques:: Implications for Alzheimer's disease pathogenesis
Jie Zhao et al.
JOURNAL OF NEUROSCIENCE (2007)
Synapse-associated protein-97 mediates α-secretase ADAM10 trafficking and promotes its activity
Elena Marcello et al.
JOURNAL OF NEUROSCIENCE (2007)
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment
Zhenyu Zhong et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction
Weiping Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Soluble amyloid precursor protein a reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats
Emma Thornton et al.
BRAIN RESEARCH (2006)
Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease
K Tang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains
H Harada et al.
NEUROSCIENCE RESEARCH (2006)
The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity
MA Cissé et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases - Retinoic acid-induced upregulation of substrate and proteinase ADAM10 during neuronal cell differentiation
K Endres et al.
FEBS JOURNAL (2005)
A review of acitretin, a systemic retinoid for the treatment of psoriasis
CS Lee et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models
NV Patel et al.
NEUROBIOLOGY OF AGING (2005)
Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells
JL Armstrong et al.
BRITISH JOURNAL OF CANCER (2005)
Imatinib mesylate blocks a non-smad TGF-beta pathway and reduces renal fibrogenesis in vivo
SN Wang et al.
FASEB JOURNAL (2005)
Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients
R Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease
F Cattabeni et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro
K Ono et al.
EXPERIMENTAL NEUROLOGY (2004)
Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)
V Matthews et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
A Olsson et al.
EXPERIMENTAL NEUROLOGY (2003)
Tumor necrosis factor-α converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation
K Endres et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome
HG Bernstein et al.
JOURNAL OF NEUROCYTOLOGY (2003)
Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
LB Yang et al.
NATURE MEDICINE (2003)
α- and β-secretase:: profound changes in Alzheimer's disease
SJ Tyler et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Levels of β-secretase BACE and α-secretase ADAM10 mRNAs in Alzheimer hippocampus
LB Gatta et al.
NEUROREPORT (2002)
β-secretase protein and activity are increased in the neocortex in Alzheimer disease
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2002)
Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2002)
A non-amyloidogenic function of BACE-2 in the secretory pathway
R Fluhrer et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life
G Weskamp et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-α converting enzyme
BE Slack et al.
BIOCHEMICAL JOURNAL (2001)
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
E Kojro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Coordinated expression of β-amyloid precursor protein and the putative β-secretase BACE and α-secretase ADAM10 in mouse and human brain
M Marcinkiewicz et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Protein kinase C-dependent α-secretase competes with β-secretase for cleavage of amyloid-β precursor protein in the trans-Golgi network
DM Skovronsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Levels of α- and β-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients
K Sennvik et al.
NEUROSCIENCE LETTERS (2000)
Share Paper
